Chengzhi Mou1, Tao Han1, Min Wang1, Meng Jiang1, Bin Liu1, Jia Hu2. 1. Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University No. 9677, Jingshi Road, Jinan 250021, Shandong, China. 2. Department of Neurosurgery, Yantaishan Hospital No. 91, Jiefang Road, Zhifu, Yantai 264000, Shandong, China.
Abstract
OBJECTIVE: To discuss the correlation of polymorphism of APOE and LRP genes to cognitive impairment and behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD) and vascular dementia (VD). METHOD: AD cases, VD cases and healthy control cases totaling 237, 255 and 234 were recruited, respectively. The mini-mental state examination (MMSE) was performed to evaluate cognitive impairment. Hamilton Depression Rating Scale (HAMD) and Hamilton Anxiety Scale (HAMA) were adopted to evaluate BPSD. Apolipoprotein E (APOE) and Low-density lipoprotein receptor-related protein gene (LRP) genotyping was carried out using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). RESULTS: (1) Frequencies of APOEε4 allele in AD group and VD group were significantly higher than that of the control (P<0.05); (2) MMSE scores of APOEε4 carriers in AD group and VD group were lower than that of non-APOEε4 carriers in the same group (P<0.05); (3) The proportion of APOEε4 carriers presenting with BPSD in AD group was considerably higher that of non-APOEε4 carriers (P<0.05). CONCLUSION: APOEε4 may be the common risk factor for cognitive impairment in AD and VD and the risk factor for BPSD in AD.
OBJECTIVE: To discuss the correlation of polymorphism of APOE and LRP genes to cognitive impairment and behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD) and vascular dementia (VD). METHOD: AD cases, VD cases and healthy control cases totaling 237, 255 and 234 were recruited, respectively. The mini-mental state examination (MMSE) was performed to evaluate cognitive impairment. Hamilton Depression Rating Scale (HAMD) and Hamilton Anxiety Scale (HAMA) were adopted to evaluate BPSD. Apolipoprotein E (APOE) and Low-density lipoprotein receptor-related protein gene (LRP) genotyping was carried out using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). RESULTS: (1) Frequencies of APOEε4 allele in AD group and VD group were significantly higher than that of the control (P<0.05); (2) MMSE scores of APOEε4 carriers in AD group and VD group were lower than that of non-APOEε4 carriers in the same group (P<0.05); (3) The proportion of APOEε4 carriers presenting with BPSD in AD group was considerably higher that of non-APOEε4 carriers (P<0.05). CONCLUSION:APOEε4 may be the common risk factor for cognitive impairment in AD and VD and the risk factor for BPSD in AD.
Authors: W K Scott; L H Yamaoka; M P Bass; P C Gaskell; P M Conneally; G W Small; L A Farrer; S A Auerbach; A M Saunders; A D Roses; J L Haines; M A Pericak-Vance Journal: Neurogenetics Date: 1998-03 Impact factor: 2.660
Authors: Breno S Diniz; Meryl A Butters; Steven M Albert; Mary Amanda Dew; Charles F Reynolds Journal: Br J Psychiatry Date: 2013-05 Impact factor: 9.319
Authors: Brian A Gordon; Safa Najmi; Phillip Hsu; Catherine M Roe; John C Morris; Tammie L S Benzinger Journal: Neuroimage Clin Date: 2015-04-30 Impact factor: 4.881
Authors: L M J Sanders; T Hortobágyi; E G A Karssemeijer; E A Van der Zee; E J A Scherder; M J G van Heuvelen Journal: Alzheimers Res Ther Date: 2020-03-19 Impact factor: 6.982